Remibrutinib Impurity 50 | CAS 425394-89-4 - Request Quote
Remibrutinib Impurity 50
| SZ CAT No: | SZ-R098054 |
| CAS No | 425394-89-4 |
| Mol.F. | C4H2Cl2N2O |
| Mol.Wt. |
165.0 |
| Inv. Status |
In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Remibrutinib Impurity 50 is chemically 4,6-dichloropyrimidin-5-ol. Remibrutinib Impurity 50 is supplied with detailed characterization data compliant with regulatory guideline. Remibrutinib Impurity 50 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Remibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 425394-89-4
Purchase 425394-89-4
Order 425394-89-4
Enquire 425394-89-4
price of 425394-89-4
425394-89-4 Supplier
425394-89-4 Manufacturer
425394-89-4 Exporter
buy high quality Remibrutinib Impurity 50
Purchase Remibrutinib Impurity 50
Remibrutinib Impurity 50 suppliers
Remibrutinib Impurity 50 manufacturers
Remibrutinib Impurity 50 price
Order Remibrutinib Impurity 50
Enquire Remibrutinib Impurity 50
Remibrutinib Impurity 50 cost
Remibrutinib Impurity 50 Supplier
Remibrutinib Impurity 50 Distributor
Remibrutinib Impurity 50 for Method Validation
Remibrutinib Reference Standard
Remibrutinib Impurity 50 for ANDA Filing
Remibrutinib Impurity 50 for Forced Degradation Studies
Remibrutinib Impurity 50 Identification Standards
Remibrutinib Impurity 50 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.